Oncimmune Holdings plc (LON:ONC – Get Free Report) shares fell 13.3% on Friday . The company traded as low as GBX 8.55 ($0.11) and last traded at GBX 10.80 ($0.13). 884,827 shares changed hands during trading, an increase of 240% from the average session volume of 259,890 shares. The stock had previously closed at GBX 12.45 ($0.15).
Oncimmune Trading Down 25.1 %
The company has a debt-to-equity ratio of 806.85, a current ratio of 1.13 and a quick ratio of 0.63. The firm’s fifty day moving average is GBX 14.22 and its two-hundred day moving average is GBX 14.85. The firm has a market capitalization of £6.91 million, a PE ratio of -310.83 and a beta of 1.19.
About Oncimmune
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Featured Stories
- Five stocks we like better than Oncimmune
- How to Use the MarketBeat Dividend Calculator
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Learn Technical Analysis Skills to Master the Stock Market
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
